RSS   Newsletter   Contact   Advertise with us

Telesta Therapeutics names chief commercial officer

Staff writer | Montreal, QC, Canada | October 9, 2015
Telesta TherapeuticsOctober 9, 2015, Montreal, QC, Canada - Telesta Therapeutics Inc., a late stage therapeutics company, announced the engagement of Brian J. Groch as chief commercial officer, a new executive position.
Mr. Groch brings more than 25 years of global commercial experience to Telesta Therapeutics, having held positions in both top-tier and start-up U.S. biopharmaceutical companies.

Most recently Mr. Groch was the Vice President of Market Access at Horizon Pharma where he played a key leadership role in building Horizon’s orphan commercial business capabilities after two major company acquisitions.

Prior to Horizon Pharma, he helped build the commercial organization at Dendreon in preparation for the launch of Provenge, successfully securing a positive national coverage decision for the first and only FDA approved immunotherapy for advanced prostate cancer.

Mr. Groch is a seasoned biotechnology and pharmaceutical industry professional with broad experience in the commercial sector including multiple product launches at Novartis and Merck where he held positions in marketing, managed markets and sales leadership.

He graduated with a B.S. in physiology and an M.S. in Business and Healthcare Administration from Central Michigan University.